Portolano Cavallo

Life Sciences

Blog

19 Apr 22
Electronic prescriptions: Recent updates
A note published by the Ministry of Health and the Ministry of Economy and Finance on March 3, 2022, announced that as of January 31, 2022, electronic prescriptions for drugs that are not reimbursed by the National Health System are operational in parts of the Italian territory.
19 Apr 22
MDCG Guidance: Notified bodies and surveillance of legacy devices
On February 16, 2022, the Medical Device Coordination Group (MDCG) established by Article 103 of Regulation (EU) 2017/745 (MDR) published a document providing guidance for appropriate surveillance regarding the transitional provisions under Article 120 of the MDR.
Electronic prescriptions: the current modalities of transmission from doctors to patients and from patients to pharmacies are extended until 31st December 2022
31 Mar 22
National Platform for Telemedicine: Agenas launches a request for proposals to set up a Public/Private Partnership
Taking advantage of the resources made available under the Next Generation EU Plan, the Italian Government has decided to launch a project for the planning, implementation and delivery of IT services facilitating access to the National Platform for Telemedicine.
EU Medical Device Coordination Group (MDCG) approves “Guidance” on appropriate surveillance of devices covered by certificates according to the MD Directives, under the transitional provisions of Article 120(3) of the MDR.
21 Mar 22
<!--:it-->Published Decree of Health Ministry identifying the ethics committees of national significance for clinical trials of medicinal products and medical devices<!--:-->
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the Life Sciences-Healthcare industry.
...
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and Venture Capital transactions.

Close
November 28, 2025
EUDAMED: As of May 28, 2026, the first four modules will become mandatory
October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
Search by...
Search
Follow us on
Follow us on